Amentum Holdings, Inc.: Form 10-Q for the period ended Jul 3, 2026
Filed with the SEC on Aug 11, 2026 and accepted by EDGAR at Aug 11, 2026, 20:25 ET.
Sections
The sections of this filing are being extracted from EDGAR and appear here in about a minute. Meanwhile, read the original on sec.gov. The main document on sec.gov.
Figures reported in this filing
Standardized line items from the XBRL in this filing, for the period ended 2026-07-03. Comparative periods it repeats are left out.
| Line item | Period | Value | XBRL concept |
|---|---|---|---|
| Revenue | 3 months2026-04-04 to 2026-07-03 | $3.49bn | us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax |
| Revenue | 9 months2025-10-04 to 2026-07-03 | $10.21bn | us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax |
| Cost of revenue | 3 months2026-04-04 to 2026-07-03 | $3.13bn | us-gaap:CostOfRevenue |
| Cost of revenue | 9 months2025-10-04 to 2026-07-03 | $9.17bn | us-gaap:CostOfRevenue |
| Selling, general and administrative | 3 months2026-04-04 to 2026-07-03 | $122.0m | us-gaap:SellingGeneralAndAdministrativeExpense |
| Selling, general and administrative | 9 months2025-10-04 to 2026-07-03 | $361.0m | us-gaap:SellingGeneralAndAdministrativeExpense |
| Operating income | 3 months2026-04-04 to 2026-07-03 | $172.0m | us-gaap:OperatingIncomeLoss |
| Operating income | 9 months2025-10-04 to 2026-07-03 | $461.0m | us-gaap:OperatingIncomeLoss |
| Income tax | 3 months2026-04-04 to 2026-07-03 | $28.0m | us-gaap:IncomeTaxExpenseBenefit |
| Income tax | 9 months2025-10-04 to 2026-07-03 | $72.0m | us-gaap:IncomeTaxExpenseBenefit |
| Net income | 3 months2026-04-04 to 2026-07-03 | $66.0m | us-gaap:NetIncomeLoss |
| Net income | 9 months2025-10-04 to 2026-07-03 | $164.0m | us-gaap:NetIncomeLoss |
| Diluted EPS | 3 months2026-04-04 to 2026-07-03 | $0.27 | us-gaap:EarningsPerShareDiluted |
| Diluted EPS | 9 months2025-10-04 to 2026-07-03 | $0.67 | us-gaap:EarningsPerShareDiluted |
| Basic EPS | 3 months2026-04-04 to 2026-07-03 | $0.27 | us-gaap:EarningsPerShareBasic |
| Basic EPS | 9 months2025-10-04 to 2026-07-03 | $0.67 | us-gaap:EarningsPerShareBasic |
| Diluted shares (weighted) | 3 months2026-04-04 to 2026-07-03 | 245,000,000 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Diluted shares (weighted) | 9 months2025-10-04 to 2026-07-03 | 245,000,000 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Operating cash flow | 9 months2025-10-04 to 2026-07-03 | $235.0m | us-gaap:NetCashProvidedByUsedInOperatingActivities |
| Capital expenditure | 9 months2025-10-04 to 2026-07-03 | $22.0m | us-gaap:PaymentsToAcquirePropertyPlantAndEquipment |
| Cash and equivalents | At period end2026-07-03 | $459.0m | us-gaap:CashAndCashEquivalentsAtCarryingValue |
| Current assets | At period end2026-07-03 | $3.19bn | us-gaap:AssetsCurrent |
| Total assets | At period end2026-07-03 | $11.20bn | us-gaap:Assets |
| Current liabilities | At period end2026-07-03 | $2.09bn | us-gaap:LiabilitiesCurrent |
| Total liabilities | At period end2026-07-03 | $6.41bn | us-gaap:Liabilities |
| Long-term debt | At period end2026-07-03 | $3.77bn | us-gaap:LongTermDebtNoncurrent |
| Current portion of debt | At period end2026-07-03 | $54.0m | us-gaap:LongTermDebtCurrent |
| Shareholders' equity | At period end2026-07-03 | $4.70bn | us-gaap:StockholdersEquity |
Source: SEC EDGAR, the filing index for accession 0001628280-26-055727. Last ingested by Listed: Oct 24, 2026, 15:06 ET. Listed shows no prices and gives no investment advice.